Multiple Myeloma

Multiple Myeloma is a cancer of plasma cells, a type of white blood cell found in the bone marrow responsible for producing antibodies. In this disease, malignant plasma cells multiply uncontrollably, crowding out healthy blood cells and producing abnormal proteins that can damage the kidneys and other organs. The excessive plasma cell growth also weakens bone structure, leading to bone pain and fractures. It predominantly affects older adults and progresses through stages from an asymptomatic precursor condition to active disease requiring treatment.

The most common symptoms include: Bone pain especially in the back and ribs; fatigue and weakness from anaemia; frequent infections; kidney problems. Early recognition is key to prompt diagnosis and effective treatment.

No, Multiple Myeloma is not contagious. It cannot spread through casual contact. However, certain risk factors and genetic predispositions may increase susceptibility.

Treatment options include: Treatment typically combines targeted therapies; immunomodulatory drugs; and corticosteroids to control the disease. Treatment should always be guided by a qualified Hematology specialist. Do not self-medicate.

While Multiple Myeloma cannot always be fully prevented, several measures can reduce risk: No known prevention; but regular monitoring for individuals diagnosed with MGUS; maintaining healthy weight.

Seek immediate medical attention if you experience symptoms of Multiple Myeloma. This is a serious condition — go to the emergency room or call 112 if symptoms are severe or rapidly worsening.